Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 9.72B 2.59B 2.27B 2.12B 1.94B 3.65B 249B 3.7B 25.12B 9.81B 123B 9.51B 424B P/E 2026 *
18.7x
P/E 2027 * -
Enterprise Value 9.41B 2.51B 2.2B 2.05B 1.88B 3.53B 241B 3.58B 24.3B 9.49B 119B 9.2B 410B EV / Sales 2026 *
5.82x
EV / Sales 2027 * 4.98x
Free-Float
38.61%
Yield 2026 *
3.23%
Yield 2027 * 3.59%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-2.46%
1 week-5.45%
Current month-10.39%
1 month-13.02%
3 months-10.39%
6 months-2.18%
Current year-2.39%
1 week 138.8
Extreme 138.8
148.5
1 month 138.8
Extreme 138.8
160.3
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
177
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Director/Board Member 98 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
-2.46%-5.45%-21.39%+9.54% 2.66B
-0.66%+0.44%+14.25%+77.26% 48.36B
+2.20%+1.41%+57.98%+112.68% 35.8B
+1.26%-0.57%-7.95%+33.74% 11.83B
-0.46%-3.06%+13.55%+78.32% 11.48B
-0.37%-0.37%+37.53%+140.99% 9.01B
+1.52%+0.39%+49.34%-7.78% 6.99B
-0.17%-2.92%+11.72%+32.23% 6.7B
-0.59%-1.95%+2.18%+179.57% 6.42B
-7.92%-13.61%-33.87%-3.07% 5.3B
Average -0.77%-2.21%+12.33%+65.35% 14.46B
Weighted average by Cap. +0.07%-0.50%+23.28%+80.69%

Financials

2026 *2027 *
Net sales 1.62B 431M 378M 352M 323M 607M 41.48B 616M 4.18B 1.63B 20.39B 1.58B 70.51B 1.87B 498M 438M 407M 374M 702M 48B 713M 4.83B 1.89B 23.6B 1.83B 81.59B
Net income 521M 139M 122M 113M 104M 195M 13.37B 198M 1.35B 526M 6.57B 510M 22.72B -
Net Debt -317M -84.44M -74.17M -68.97M -63.29M -119M -8.13B -121M -819M -320M -4B -310M -13.82B -404M -108M -94.52M -87.9M -80.66M -152M -10.36B -154M -1.04B -408M -5.1B -395M -17.62B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-07-26 SAR 138.90 -2.46% 30,360
26-07-23 SAR 142.40 -2.86% 82,009
26-07-22 SAR 146.60 -0.34% 34,124
26-07-21 SAR 147.10 +0.07% 27,180
26-07-20 SAR 147.00 +1.87% 9,370
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
138.90SAR
Average target price
164.24SAR
Spread / Average Target
+18.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock